Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis.
Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
Follow-up of hypertension in patients with multiple sclerosis.
Beta interferon decision is 'disappointing'.
Cognitive processess and cognitive reserve in multiple sclerosis.
Myelin-reactive type B T cells and T cells specific for low-affinity MHC-binding myelin peptides escape tolerance in HLA-DR transgenic mice.
The immunomodulator decoy receptor 3 improves locomotor functional recovery after spinal cord injury.
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study.
Extracranial Head and Neck Schwannomas: Our Experience.
Stem Cells Therapy in Multiple Sclerosis - A New Hope for Progressive Forms.
Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity.
The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination.
The Pharmacokinetics and Dosing of Oral 4-Methylumbelliferone for Inhibition of Hyaluronan Synthesis in Mice.
Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis.
Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
A Rare Cause of Hemifacial Spasm: Papillary Oncocytic Cystadenoma.
Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective.
Central Nervous System Pathology Progresses Independently of KC and CXCR2 in Globoid-Cell Leukodystrophy.
Myelination: Both Mindful and Mindless?
Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration.
US health insurance is an obstacle to disease-modifying treatments in MS.
The contribution of neutrophils to CNS autoimmunity.
Pages
« first
‹ previous
…
758
759
760
761
762
763
764
765
766
…
next ›
last »